Tobias Nordström

Tobias Nordström

Affiliated to research

Email:
tobias.nordstrom@ki.se
Organisation:

Clinical urologist and researcher dedicated to improve diagnostics and treatment of prostate cancer and other urological conditions.

About me

Tobias Nordström is a clinically active urologist, focusing on the detection and treatment of malignancies in the prostate and kidney, as well as treating general urological conditions. He started practicing urology in 2007 and has achieved degrees in General Surgery and Urology at Danderyd's Hospital. He was awarded Fellow of the European Board of Urology (FEBU) in 2015. 

Tobias Nordström defended his thesis "Predicting Prostate Cancer- on the use of biomarkers in Prostate Cancer Diagnostics" in January 2015 after which he undertook international postdoctoral studies at University of California, San Francisco.

He now combines clinical surgical practice at Danderyds Hospital with independent research at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. Centrepieces of his work includes leading guidelines development and implementing improvements in clinical care such as targeted prostate biopsies and imaging.

Research description

The over-arching aim of Tobias Nordström's research is to improve detection and treatment of prostate cancer. Current work emanates from different perspectives, resulting in several different projects. 

An improved diagnostic chain for prostate cancer The hypothesis is that combining improved blood-based testing and imaging techniques will improve detection of prostate cancer. Tobias Nordström is principal investigator for the STHLM3MR-projects, aiming to investigate the value of Magnetic Resonance Imaging (MRI) in prostate cancer detection. The STHLM3MR Main study is a large randomized study, exploring a combination of using the STHLM3 test and targeted biopsies using MRI/Fusion techniques. 

Traditional tools for prostate cancer detection Several tools are already available to aid decisions in prostate cancer diagnostics, but evidence is often scarce. Using contemporary, high-quality data, Dr Nordström systematically explores the value of traditionally used markers of prostate cancer risk such as prostate volume, voiding symptoms, repeated blood-testing et cetera.

Current diagnostics of prostate cancer Using the population-based cohort STHLM0, Dr Nordström works on describing how detection of prostate cancer is currently being performed. For example, he has described current patterns of PSA-testing, use of prostate biopsies and frequency of biopsy-related complications.

Education

  • 2015-  Postdoc (Dept of Medical Epidemiology and Biostatistics, KI)
  • 2015-  Clinical Urologist (Danderyd's Hospital)
  • 2015   Fellow of the European Board of Urology (FEBU)
  • 2015   Postdoc (University of California, San Francisco)
  • 2015   Ph.D. (Dept Clinical Sciences at Danderyd's Hospital, KI)
  • 2013   General Surgeon (Danderyd's Hospital)
  • 2007   M.D. (KI)

Academic honours, awards and prizes

2017  European Meeting on Urinary Cancers (EMUC) - Best poster award

2017  Astellas Cutting Edge Award

2016  European Association of Urology (EAU) Annual Meeting - Best poster award

2014  StratCan International Postdoc award

2011  StratCan Ph.D. award

2011  Research Resident